Search company, investor...
Diabeloop company logo

Diabeloop

diabeloop.fr

Founded Year

2015

Stage

Series C | Alive

Total Raised

$124.33M

Last Raised

$75M | 8 mos ago

About Diabeloop

Diabeloop is a medical device company developing an artificial pancreas system that enables the complete automation of insulin delivery and uses information from a continuous blood glucose monitor (CGM) to calculate and deliver the optimal insulin dose to patients in real-time. The device has the potential to provide more accurate regulation of blood-sugar levels in insulin-dependent people with Type 1 diabetes, preventing hypoglycemic and hyperglycemic events and other long-term complications that may arise from diabetes. Diabeloop was founded in 2015 and is based in Grenoble, France.

Headquarters Location

155-157 Cours Berriat

Grenoble, 38028,

France

Missing: Diabeloop's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Diabeloop's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Diabeloop

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Diabeloop in 2 CB Insights research briefs, most recently on Oct 28, 2022.

Expert Collections containing Diabeloop

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Diabeloop is included in 6 Expert Collections, including Digital Health.

D

Digital Health

13,864 items

Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)

C

Conference Exhibitors

6,062 items

Companies that will be exhibiting at CES 2018

M

Medical Devices

8,606 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,598 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Diabetes

2,051 items

H

Health IT

7,901 items

Diabeloop Patents

Diabeloop has filed 1 patent.

The 3 most popular patent topics include:

  • Blood tests
  • Diabetes
  • Insulin therapies
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/1/2018

11/1/2022

Diabetes, Insulin therapies, Implants (medicine), Experimental cancer drugs, Biological engineering

Grant

Application Date

8/1/2018

Grant Date

11/1/2022

Title

Related Topics

Diabetes, Insulin therapies, Implants (medicine), Experimental cancer drugs, Biological engineering

Status

Grant

Diabeloop Frequently Asked Questions (FAQ)

  • When was Diabeloop founded?

    Diabeloop was founded in 2015.

  • Where is Diabeloop's headquarters?

    Diabeloop's headquarters is located at 155-157 Cours Berriat, Grenoble.

  • What is Diabeloop's latest funding round?

    Diabeloop's latest funding round is Series C.

  • How much did Diabeloop raise?

    Diabeloop raised a total of $124.33M.

  • Who are the investors of Diabeloop?

    Investors of Diabeloop include Supernova Invest, Kreaxi, Agir a dom, Credit Agricole, Odyssee Venture and 19 more.

  • Who are Diabeloop's competitors?

    Competitors of Diabeloop include Happy Bob, Capillary Biomedical, Insulclock, DIABNEXT, Ideal Medical Technologies and 9 more.

Compare Diabeloop to Competitors

DreaMed Diabetes Logo
DreaMed Diabetes

DreaMed Diabetes develops health solutions and decision support tools using algorithms for the optimization of intensive insulin therapy for the benefit of people with Type 1 and Type 2 diabetes. The company's first product, GlucoSitter, was developed for closed-loop insulin therapy and was licensed to Medtronic. The company's latest product, Advisor, its decision support technology platform for determining the optimal patient-specific insulin treatment plans leading to balanced glucose levels in people with diabetes. The system uses event-driven machine learning and logic technology in order to process multiple personalized parameters, such as insulin delivery data, glucose readings, meal data and more into an informed and optimized insulin dosing treatment plan.

I
Ideal Medical Technologies

Ideal Medical Technologies is a company that aims to improve healthcare through technological innovation. The company's initial project will be the creation of an artificial pancreas for use in the hospital setting. This device will utilize an artificial intelligence-based glucose controller to provide optimal glucose control for both diabetic patients and ICU patients. The company was founded in 2013 and is based in Asheville, North Carolina.

MedicSen Logo
MedicSen

Medicsen delivers a diabetes management app that combines smart patch administration, glucose sensors, and artificial intelligence.

I
Insulclock

Insulclock is the developer of a device that adheres to medications such as insulin and communicates directly via an app with smartphones to inform them when and how much medication has been given. It was founded in 2015 and is based in Madrid, Spain.

Fractyl Health Logo
Fractyl Health

Fractyl develops Revita DMR, a same-day, minimally-invasive procedure to treat two highly prevalent metabolic diseases: type 2 diabetes and NAFLD/NASH. The Revita DMR procedure harnesses current insights from bariatric science to address a root cause of insulin resistance in the duodenum. Fractyl's approach aims to improve the health of patients with metabolic diseases with device-based interventions for patients and healthcare systems.

H
Happy Bob

Happy Bob uses real-time CGM data and turns diabetes management into more rewarding, playful moments that help keep blood sugar more stable. The company was founded in 2018 and is based in Espoo, Finland.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.